Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTSL.L Regulatory News (TSL)

  • There is currently no data for TSL

Board Change

11 May 2020 09:40

RNS Number : 4797M
ThinkSmart Limited
11 May 2020
 

11 May 2020

 

ThinkSmart Limited

("ThinkSmart" or the "Company")

 

Board Change

 

ThinkSmart announces that Roger McDowell, Non-Executive Director of the Company, will retire from the Board of the Company at the next Annual General Meeting, expected to be in November 2020. Following Roger's retirement, the ThinkSmart Board will comprise Ned Montarello (Executive Chairman and interim CEO), Gary Halton (CFO), Peter Gammell (Non-Executive Director) and David Adams (Non-Executive Director).

 

Roger joined the Board of ThinkSmart in December 2016 when the Company listed on AIM of the London Stock Exchange.

 

Ned Montarello, Executive Chairman and interim CEO, commented:

 

"On behalf of the Board, I should like to thank Roger for his service to ThinkSmart over the past 3 and a half years during which time the Company has undergone significant change including the sale of 90% of its Clearpay business to the Australian listed Afterpay Ltd. We wish him the very best for the future."

 

 

 

For further information contact:

ThinkSmart Limited

Via Buchanan

Ned Montarello

Canaccord Genuity Ltd (Nominated Adviser and Broker)

+44 (0)20 7523 8350

Sunil Duggal

 

David Tyrrell

 

Tom Diehl

 

Buchanan

+44 (0)20 7466 5000

Giles Stewart

Victoria Hayns

Toto Berger

About ThinkSmart Limited

ThinkSmart Limited is a specialist digital payments platform operator and investor. In 2018 ThinkSmart sold 90% of its Clearpay subsidiary to Afterpay Ltd and retains the 10% holding. ThinkSmart's operating business provides retail finance solutions for both consumers and businesses, underpinned by its innovative and scalable proprietary technology platform, 'SmartCheck'. Since it commenced operations in the UK in 2003, the Group has processed in excess of 350,000 individual applications.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAABMPTMTJBMIM
Date   Source Headline
22nd Dec 20164:42 pmRNSBuy-back class ruling
22nd Dec 20163:05 pmRNSGrant of LTIP Awards
16th Dec 20168:02 amRNSAppointment of Joint Corporate Broker
15th Dec 20167:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Dec 20165:00 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th Dec 20167:00 amRNSChange in ISIN and SEDOL
2nd Dec 20168:06 amRNSAdmission to AIM and First Day of Dealings
21st Apr 20082:47 pmRNSIssue of Equity-TissueScience
8th Apr 20082:26 pmRNSTissue Science Equity Issue
2nd Apr 20084:44 pmRNSTissue Science Laboratories
2nd Apr 200812:18 pmRNSTissue Science Laboratories
1st Apr 20087:57 amRNSEPT Disclosure
28th Mar 20083:26 pmRNSHolding(s) in Company
28th Mar 200812:02 pmRNSHolding(s) in Company
28th Mar 20087:02 amRNSRule 8.1- Tissue Science Lab
27th Mar 200811:41 amRNSHolding(s) in Company
27th Mar 20089:47 amRNSRule 8.1 - Tissue Science Lab
25th Mar 20087:01 amRNSRule 8.1- Tissue Science Lab.
19th Mar 200811:29 amRNSHolding(s) in Company
19th Mar 20089:29 amRNSRule 8.1- Tissue Science Lab.
18th Mar 20089:25 amRNSRule 8.1- Tissue Science Lab.
18th Mar 20089:22 amRNSRule 8.1- Tissue Science Lab.
14th Mar 20084:31 pmRNSRule 8.3- Tissue Science
14th Mar 20082:21 pmRNSRule 8.3- Tissue Science
14th Mar 200811:38 amRNSHolding(s) in Company
14th Mar 200811:38 amRNSHolding(s) in Company
14th Mar 200811:15 amRNSRule 8.3- Tissue Science
14th Mar 20088:09 amRNSRule 8.1- Tissue Science Lab
13th Mar 20082:26 pmBUSRule 8.3 - Tissue Science Laboratories Plc
13th Mar 20082:05 pmRNSRule 8.1- Tissue Science Lab.
13th Mar 20081:07 pmRNSEPT Disclosure-Amend
13th Mar 200811:05 amPRNRule 8.3 - Tissue Science Laboratories Plc
13th Mar 20088:36 amRNSEPT Disclosure
13th Mar 20087:00 amRNSRule 8.1- Tissue Science Lab.
12th Mar 20083:55 pmRNSOffer Document Posted
12th Mar 20087:01 amRNSOffer for Tissue Science Lab.
12th Mar 20087:01 amRNSFinal Results & Cash Offer
17th Jan 20087:00 amRNSPositive Study Results
12th Nov 200710:47 amRNSHolding(s) in Company
7th Nov 20074:22 pmRNSHolding(s) in Company
28th Sep 20077:02 amRNSInterim Results
10th Sep 20077:01 amRNSNotice of Results
28th Aug 200712:26 pmRNSHolding(s) in Company
17th Aug 20073:28 pmRNSAIM Rule 26 Compliance
6th Jul 20072:25 pmRNSResult of AGM
6th Jul 20077:00 amRNSPre-close Trading Statement
29th Jun 20074:00 pmRNSTotal Voting Rights
14th Jun 20077:00 amRNSNotice of AGM
31st May 200712:00 pmRNSExercising of Options
16th Apr 20077:01 amRNSR&D Teach-In

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.